Profile data is unavailable for this security.
About the company
Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. Advanced Wound Care includes advanced dressings for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories, and personalized services for individuals with a stoma. Continence Care includes products and services for people with urinary continence issues related to spinal cord injuries and other causes. Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.
- Revenue in GBP (TTM)1.73bn
- Net income in GBP159.23m
- Incorporated2016
- Employees10.48k
- LocationConvaTec Group PLC7th Floor, 20 Eastbourne TerraceLONDON W2 6LGUnited KingdomGBR
- Websitehttps://www.convatecgroup.com/
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Ambu A/S | 707.00m | 63.21m |
| Asker Healthcare Group AB | 1.34bn | 38.18m |
| Amplifon SpA | 2.09bn | 100.36m |
| Medacta Group SA | 560.73m | 82.39m |
| Sectra AB | 182.14m | 52.62m |
| Ottobock SE & Co KgaA | 1.43bn | 50.26m |
| DiaSorin SpA | -86.80bn | -86.80bn |
| Ypsomed Holding AG | 745.73m | 183.70m |
| Getinge AB | 2.85bn | 183.82m |
| ConvaTec Group PLC | 1.73bn | 159.23m |
| Demant A/S | 2.67bn | 275.13m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| Artisan Partners LPas of 31 Dec 2024 | 97.98m | 5.01% |
| Massachusetts Financial Services Co.as of 21 Nov 2025 | 97.78m | 5.00% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2024 | 95.17m | 4.87% |
| Black Creek Investment Management, Inc.as of 06 Aug 2025 | 82.50m | 4.22% |
| Fidelity Management & Research Co. LLCas of 22 Sep 2025 | 68.71m | 3.52% |
| Royal London Asset Management Ltd.as of 02 Jan 2026 | 55.74m | 2.85% |
| Schroder Investment Management Ltd.as of 02 Jan 2026 | 54.24m | 2.78% |
| BlackRock Investment Management (UK) Ltd.as of 31 Dec 2024 | 53.84m | 2.75% |
| FIL Investment Advisors (UK) Ltd.as of 16 Dec 2025 | 48.96m | 2.51% |
| FIL Investments Internationalas of 02 Jan 2026 | 47.97m | 2.45% |
